Form 13-F position report

INVO BIOSCIENCE INC COM STK (N

Reported by FRONTIER INVESTMENT MGMT CO

IVOB CUSIP 44984F104 Manager CIK 0001316539

First reported at 50,000 shares this quarter.

New
% of reported 13F value < 0.01% This manager · Q3 2015
Shares 50,000 Quarter-end amount reported
Reported value $23,000 Fair value at quarter end
Consecutive quarters held 1 Through Q3 2015

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2015-09-30 23000
2015-12-31 35000
2016-03-31 7000
2016-06-30 8000
2016-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

5 quarters
Quarterly reported position history for INVO BIOSCIENCE INC COM STK (N held by FRONTIER INVESTMENT MGMT CO.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2016 Reduced 0 -20,200 (-100.0%) 0 $0 2016-11-08
Q2 2016 Unchanged 20,200 0 (0.0%) < 0.01% $8,000 2016-08-12
Q1 2016 Reduced 20,200 -29,900 (-59.7%) < 0.01% $7,000 2016-05-13
Q4 2015 Added 50,100 +100 (0.2%) < 0.01% $35,000 2016-02-11
Q3 2015 New 50,000 +50,000 (0.0%) < 0.01% $23,000 2015-11-16

Who else reported the position

1 manager reported INVO BIOSCIENCE INC COM STK (N for Q3 2015.

Managers reporting INVO BIOSCIENCE INC COM STK (N in Q3 2015.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FRONTIER INVESTMENT MGMT CO This report New 50,000 +50,000 < 0.01% $23,000 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2015
Filed
November 16, 2015
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
50,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.